The group’s principal activity is tp provide drug development and contract manufacturing serving to the pharmaceutical and biotechnology industries. The group was founded in early 1990’s. The group’s service includes formulation evaluation, analytical services, clinical manufacturing, biotechnology services, regulatory support, formulation development and commercial manufacturing. The group operates from the United States.
